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586 Contemporary ReviewsOSA is a commonly encountered comorbid condition in surgical patients. The risk of cardio-
pulmonary complications is increased by two to threefold with OSA. Among the different
treatment options for OSA, CPAP is an efﬁcacious modality. This review examines the evidence
regarding the use of CPAP in the preoperative and postoperative periods in surgical patients
with diagnosed and undiagnosed OSA. CHEST 2016; 149(2):586-597
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in the general population with estimated
prevalence of at least 9% to 25%.1 Indeed, in
a recent population-based study in
Switzerland, the prevalence of moderate to
severe OSA was 23.4% in women and
49.7% in men.2 The prevalence of OSA in
surgical patients using International
Classiﬁcation of Disease-9 codes has been
reported to be 7% to 10%.3-5 However, using
polysomnography (PSG), the prevalence of
OSA in surgical patients is expected to be
signiﬁcantly higher than simply using
International Classiﬁcation of Disease-9
codes from administrative databases. Indeed,
the prevalence may be as high as 70% in
high-risk populations such as patients
undergoing bariatric surgery.6,7 Surgical
patients with OSA pose a signiﬁcant clinical
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in Sleep Medicinebecause of OSA’s associations with several
comorbidities, including cardiovascular
disease, heart failure, arrhythmias,
hypertension, stroke, and metabolic
syndrome.8-11 During the perioperative
period, sleep is disrupted and the severity
of sleep-disordered breathing (SDB) is
increased postoperatively in surgical patients
with OSA.12,13
The American Society of Anesthesiologists
published a practice guideline recommending
preoperative screening to identify undiagnosed
OSA, preoperative initiation of CPAP if
possible, and postoperative monitoring
of patients with OSA.14,15 Perioperative
complications related to OSA are increasingly
linked to malpractice lawsuits with severe
ﬁnancial penalties.16,17 The lack of evidence
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the signiﬁcant cost of guideline implementation have
created a dilemma between potentially improved
postoperative adverse events and increased health-care
resource utilization. In practice, fewer than 20% of
patients with a diagnosis of OSA receive CPAP
therapy, are observed in advanced care settings, or
both.18 This review examines the evidence regarding
the use of CPAP in the preoperative and postoperative
periods in surgical patients with diagnosed and
undiagnosed OSA.Surgical Patients With OSA and Perioperative
Complications
A close relationship exists among OSA, sleep, and
anesthesia. Upper airway behavior during sleep serves
to some extent as a surrogate of airway behavior
during anesthesia and recovery from anesthesia.
Likewise, upper airway abnormalities observed by
anesthesiologists during the perioperative period is
likely to predict upper airway behavior during sleep.19
A patient with an upper airway that is prone to
collapse may also be at increased risk of compromised
arousal mechanism in the postoperative period. Several
large database studies and two meta-analysis have
shown that patients with OSA have increased risk of
postoperative complications.3,4,20-25 Two recent meta-
analysis of 13 and 17 studies indicate that, compared
with patients with OSA, patients with OSA have a
higher incidence of respiratory complications,
postoperative cardiac events, and increased ICU
transfer.24,25 In line with the meta-analysis, ﬁve recent
studies using data from large national and
international databases including millions of patients
demonstrated a signiﬁcantly increased risk of atrial
ﬁbrillation, respiratory failure, aspiration pneumonia,
ARDS, increased emergent postoperative endotracheal
intubation, and need for postoperative ventilation
among patients with a diagnosis of OSA vs control
subjects.3,4,20-22,26 D’Apuzzo et al20 demonstrated that
there is increased mortality in OSA vs patients without
OSA undergoing revision joint arthroplasty (OR, 1.9;
P ¼ .002). That this study included patients
undergoing revision arthroplasty may suggest a higher
burden of comorbidities. Paradoxically, the increased
risk of cardiopulmonary complications did not
translate into increased risk of in-hospital mortality in
two studies.4,20 There may be several reasons behind
the reduction in in-hospital mortality: (1) patients with
OSA may have received more vigilant care; (2) patientsjournal.publications.chestnet.orgwith OSA may have exhibited signs of deterioration
earlier in their hospital course; (3) the reason behind
respiratory failure in patients with OSA may have been
easier to treat (eg, respiratory failure from upper
airway compromise vs aspiration pneumonia or
ARDS); or (4) in the control group, patients may have
undiagnosed OSA with increased risk of mortality and
morbidity. Indeed, in two studies of postsurgical
patients,4,20 those with an OSA diagnosis who
developed respiratory failure were intubated earlier
and received mechanical ventilation for a shorter
period, suggesting that the cause of respiratory failure
was rapidly reversible, perhaps related to upper airway
complications resulting from sedatives and opioid
analgesics.
In the general population, a signiﬁcant proportion of
patients with moderate to severe OSA remains
undiagnosed.27 This corollary may also apply to the
surgical patients in the perioperative period. In a
retrospective nested cohort study, preoperative
screening followed by PSG was performed to identify
patients with OSA, and the results were blinded to the
perioperative care team. Both anesthesiologists and
surgeons failed to identify a majority of the newly
diagnosed patients with moderate to severe OSA.28
Patients with undiagnosed OSA presenting for surgery
may have further increase in cardiopulmonary
complications.29-31Postoperative Use of CPAP in Surgical Patients
Without OSA
The efﬁcacy of CPAP in patients without a diagnosis of
OSA has been well-established by a recent meta-analysis
of nine randomized controlled trials (RCTs) in patients
undergoing abdominal surgery.32 These studies have
shown that perioperative use of CPAP leads to a
reduction in the rate of postoperative pulmonary
complications. In 200 patients who developed
hypoxemia immediately after undergoing major
abdominal surgery, the use of postoperative CPAP at
7.5 cm H2O plus supplemental oxygen using a helmet
interface led to a reduction in the incidence of
endotracheal intubation, pneumonia, infection, and
sepsis when compared with supplemental oxygen
alone.33 Signiﬁcant reduction in the rate of pulmonary
complications with the prophylactic use of nasal CPAP
was also demonstrated in patients undergoing
thoracoabdominal aortic surgery and cardiac surgery.34,35587
Preoperative and Postoperative CPAP in
Surgical Patients With OSA
The number of surgical cases performed globally is
increasing, and an estimated 250 million major surgeries
are being performed each year.36 With the global rise of
obesity, the prevalence of OSA will likely continue to
rise.1,2 Perioperative care of patients with OSA will be an
increasing challenge. The concept of perioperative
surgical home, encompassing optimization of surgical
patient’s health status from preoperative period to
postoperative discharge care for conditions, such as
coronary heart disease, congestive heart failure, COPD,
or diabetes, has become the new reality.37 The same
concept applies to patients with suspected or diagnosed
OSA presenting for surgery, where the association of
OSA with postoperative complications has been a wake-
up call for action.38 Anesthesiologists are in an ideal
position to identify patients with SDB, optimize their
perioperative management, and contribute to their
continuum of care. Because CPAP therapy has long-
term health beneﬁts for patients with OSA, preoperative
clinics may provide an opportunity for identiﬁcation of
patients with undiagnosed OSA and initiation of
treatment. In a recent study, surgical patients were
screened for OSA in a preoperative clinic and were
offered CPAP therapy. Those who were CPAP-adherent
had better sleep quality, less daytime sleepiness, and
reduction of medication usage for associated medical
diseases.39 For patients with OSA presenting for surgery,
perioperative clinicians may face a variety of scenarios:
patients with (1) diagnosed OSA with appropriate
adherence to effective therapy, (2) diagnosed OSA but
not adherent to prescribed therapy, and (3) undiagnosed
OSA. Patients who are treated and adherent to CPAP
should continue their CPAP in the postoperative period.
Those patients with diagnosed OSA who are not
adherent to therapy or undiagnosed OSA pose a more
signiﬁcant clinical challenge.
Effects of CPAP on Postoperative Outcomes in
Surgical Patients With OSA
In patients with OSA, CPAP has been shown to have
beneﬁcial effects on postoperative adverse events. In a
case series by Rennotte et al40, two patients with OSA
without CPAP suffered postoperative adverse events and
one patient died, whereas 14 patients with OSA treated
with CPAP had uneventful postoperative courses. In a
retrospective case-control study, patients with OSA
without CPAP had more postoperative complications
than patients with OSA treated with CPAP (44% vs 27%,
P ¼ .02). Unplanned ICU transfer was also signiﬁcantly588 Contemporary Reviews in Sleep Medicinehigher in patients with OSA without CPAP treatment
and length of stay was 1 day longer.41 In a retrospective
cohort match study, Liao et al42 found that 30% of the
patients with OSA not using home CPAP developed
an adverse event such as upper airway obstruction or
hypoxemia, resulting in the initiation of postoperative
CPAP. Studies on the efﬁcacy of CPAP on postoperative
outcomes are shown in Table 1.30,31,40-46
A recent meta-analysis of six studies including 904
patients examined the effectiveness of CPAP therapy on
postoperative outcomes, postoperative apnea hypopnea
index (AHI), and length of stay in surgical patients with
OSA plus CPAP therapy vs patients with OSA without
CPAP therapy.47 There was no signiﬁcant difference in
postoperative adverse events between the CPAP and
no-CPAP groups (risk ratio, 0.88; 95% CI, 0.73-1.06;
P ¼ .19). Patients with OSA who used CPAP either
preoperatively and/or postoperatively compared with
no-CPAP had a risk ratio of 0.88 (0.73-1.06) and a
12% risk reduction of postoperative adverse events
with a corresponding number needed to treat to
beneﬁt of 45.47 The nonsigniﬁcant beneﬁt of CPAP on
postoperative adverse events may have been related to
the relatively small sample size of 904 patients and an
overall low incidence of postoperative complications in
the meta-analysis. Other potential reasons may have
been suboptimal CPAP adherence in the perioperative
period. However, the meta-analysis revealed that
perioperative CPAP signiﬁcantly reduced postoperative
AHI from the preoperative baseline AHI (preoperative
AHI vs postoperative AHI: 37  19 vs 12  16
events/h).47 There was also a trend toward signiﬁcance
for reduction in the length of hospital stay of 0.4 days
favoring the CPAP group (CPAP vs no-CPAP: 4.0  4
vs 4.4  8 days, P ¼ .05).47
Even though ﬁve studies supported the use of CPAP in
the perioperative period, they were not included in the
meta-analysis by Nagappa et al47 (Table 2), because of a
lack of data in either the study group and/or control
group. In a retrospective chart review by Meng et al,48
patients who did not use CPAP had a signiﬁcantly
higher incidence of postoperative hypertension (CPAP
vs no-CPAP group: 18% vs 29%; P ¼ .013) and
oxygen desaturations (CPAP vs no-CPAP group:
5% vs 43%; P ¼ .012). Also, the length of postanesthesia
care unit (PACU) stay was longer in the no-CPAP group
when compared with the CPAP group (211  82 min
vs 159  78 min, P ¼ .029). Neligan et al49 conducted an
RCT on morbidly obese patients with OSA undergoing
laparoscopic bariatric surgery. The administration of[ 1 4 9 # 2 CHES T F E B R U A R Y 2 0 1 6 ]
TABLE 1 ] Effect of CPAP on Postoperative Outcomes in Surgical Patients With OSA
Author Study Type No. Result
Rennotte et al, 199540 Case series report 16 No-CPAP vs CPAP: 2 vs 14
First patient died; second patient: serious postop Cx
14 patients nasal CPAP Rx, no Cx
Gupta et al, 200141 Retrospective
case-control
study
101 No-CPAP vs CPAP group: 68 vs 33
Any Cx: 44% vs 27% (P ¼ .1)
Serious Cx: 31% vs 9% (P ¼ .02)
Total ICU stay: 32.3% vs 3% (P ¼ .001)
Unplanned ICU stay: 27.9% vs 3% (P ¼ .003)
Hospital stay: 7  3 vs 6  2 days (P ¼ .03)
Jensen et al, 200843 Prospective
cohort study
284 No-CPAP/BiPAP vs CPAP/BiPAP: 140 vs 144
Pneumonia: 2.1% vs 0.7% (NS)
Hospital stay: 2.2 vs 2.7 days (P ¼ .244)
Liao et al, 200942 Retrospective
matched-cohort
study
480 OSA vs non-OSA: 240 vs 240
Postop Cx: 44% vs 28% (P < .05)
SPO2 < 90%: 17% vs 8%
No-CPAP vs CPAP: 90 vs 150
Postop Cx: 46.6% vs 40.6% (P ¼ .36)
Liao et al, 201344 RCT 177 No-APAP vs APAP: 90 vs 87
Postoperative Cx: 48.3% vs 48.3% (P ¼ .939)
Preoperative AHI vs postoperative AHI (NS)
APAP: 30.1 to 3.0 (P < .001)
No-APAP: 30.4 to 31.9 (P ¼ .302)
Hospital stay: 4.3  5.5 vs 3.5  6.2 days (P ¼ .36)
O’Gorman et al, 201345 RCT 138 No-APAP vs APAP
Any Cx: 20.9% vs 23.3% (P ¼ 1.0)
No signiﬁcant difference between LOS (P ¼ .65)
Mutter et al, 201430 Matched-cohort
study
20,488 Respiratory Cx
Overall: 2.08, 95% CI, 1.35-2.19, P ¼ .0008
Diagnosed OSA vs undiagnosed OSA
OR, 0.68; 95% CI, 0.27-1.71; P ¼ .41
Cardiovascular Cx
Undiagnosed OSA vs matched cohort control
OR, 2.20; 95% CI, 1.16-4.17; P ¼ .02
Diagnosed OSA vs matched cohort control
OR, 0.75; 95% CI, 0.43-1.28; P ¼ .29
Diagnosed OSA vs undiagnosed OSA
OR, 0.34; 95% CI, 0.15-0.77; P ¼ .009
Abdelsattar et al, 201531 Prospective
cohort study
2646 Untreated OSA vs treated OSA: 1,465 vs 1,181
Cardiopulmonary Cx
6.7% vs 4.0%; aOR, 1.8; P ¼ .001
Unplanned reintubations
aOR, 2.5; P ¼ .003
Myocardial infarction
aOR, 2.6; P ¼ .031
Proczko et al, 201446 Retrospective
cohort
693 Diagnosed OSA and Rx with CPAP vs STOP-Bang $ 3
99 vs 182
Hypertension 11.1% vs 11.5% (P ¼ .9142)
Death: 0% vs 1% (P ¼ .5142)
Hospital stay: 3.2 vs 4.1 days (P < .0001)
Pneumonia: 2% vs 9.3% (P < .04)
Reintubation: 0% vs 3.8% (P ¼ .1442)
ICU admission: 0% vs 1% (P ¼ .5142)
AHI ¼ apnea hypopnea index; aOR ¼ adjusted odds ratio; APAP ¼ autotitrated positive airway pressure; BiPAP ¼ bilevel positive airway pressure;
Cx ¼ complications; LOS ¼ length of hospital stay; NS ¼ not signiﬁcant; RCT ¼ randomized controlled trial; Rx ¼ treated; SPO2 ¼ oxygen saturation;
STOP-Bang ¼ snoring, tired, observed, pressure, BMI, age > 50 years, neck size large, gender.
journal.publications.chestnet.org 589
TABLE 2 ] Additional Studies That Supported the Use of CPAP in Surgical Patients With OSA
Author
Study Type and Surgical
Procedure No. Result
Ramirez et al,
200952
Retrospective
review
Roux-en-Y gastric
bypass
310 Postoperative CPAP vs no-CPAP: 91 vs 219
Basal atelectasis: 3.3% vs 1.8% (P > .05)
Wound infection: 4.4% vs 0.45% (P > .05)
GI bleeding: 0% vs 0.45% (NS)
Overall morbidity: 4.5% vs 3.6% (P > .05)
Hallowell et al,
200750
Retrospective
review
Bariatric surgery
890 Selective OSA testing (1998-2003) vs mandatory OSA testing and
perioperative CPAP Rx (2004-2005)
Respiratory-related ICU stay
34% vs 9% (P < .001)
Meng et al,
201048
Retrospective
review
Roux-en-Y gastric
bypass
356 Perioperative CPAP (102) vs no-CPAP (254)
Nausea in PACU: 36% vs 35% (P ¼ .91)
Emesis in PACU: 19% vs 17% (P ¼ .8)
Hypertension: 18% vs 29% (P ¼ .013)
O2 disturbance: 5% vs 13% (P ¼ .012)
PACU stay: 159  78 vs 211  82 (P ¼ .029)
Reintubation: 2% vs 5% (P ¼ .45)
ICU admission: 2% vs 5% (P ¼ .45)
Neligan et al,
200949
RCT 40 Postextubation CPAP vs PACU CPAP
FEV1: coefﬁcient, 0.37; SE, 0.13; P < .003; 95% CI, 0.13-0.62
FVC: coefﬁcient, 0.39; SE, 0.14; P < .006; 95% CI, 0.11-0.66
PEFR: coefﬁcient, 0.82; SE, 0.31; P < .008; 95% CI, 0.21-0.1.4
Huerta et al,
200251
Prospective review
Roux-en-Y gastric
bypass
1067 No correlation between CPAP use and anastomotic leak (P ¼ .06)
PACU ¼ postanesthesia care unit; PEFR ¼ peak expiratory ﬂow rate. See Table 1 legend for expansion of other abbreviations.CPAP immediately after extubation improved
spirometric lung functions at 1 h and 24 h after extubation
in the operating room vs CPAP that was started in the
PACU. Hallowell et al50 found that compulsory screening
for OSA and perioperative treatment with CPAP therapy
decreased respiratory-related ICU stays from 34% to
1% (P < .001). Huerta et al51 prospectively evaluated 420
patients with OSA undergoing bariatric surgery, of which
159 patients were dependent on CPAP. There were no
respiratory complications and no positive correlations
between CPAP use and anastomotic leak. This suggests
that CPAP is an effective tool for treating hypoventilation
after gastric bypass without necessarily increasing the risk
of postoperative anastomotic leaks.51 However, after
laparoscopic Roux-en-Y gastric bypass, Ramirez et al52
found that there was no signiﬁcant difference in the
overall morbidity between those who used CPAP
postoperatively and those who did not (4.5% vs
3.5%, P > .05).
Two recent large studies further support the beneﬁts
of CPAP in patients with diagnosed and undiagnosed
OSA.30,31 Mutter et al30 linked a clinical database of
PSG data for patients with newly diagnosed OSA with
a CPAP prescription to a large provincial health590 Contemporary Reviews in Sleep Medicineadministrative database and compared postoperative
outcomes in patients with OSA, before and after OSA
diagnosis, with matched control subjects from the
general population who had a low risk of having OSA.
Patients diagnosed with OSA had signiﬁcantly reduced
risk of cardiovascular adverse events vs undiagnosed
patients with OSA (OR, 0.34, 95% CI, 0.15-0.77,
P ¼ .009). The risk of cardiovascular complications,
primarily cardiac arrest and shock, was signiﬁcantly
different between 1,489 undiagnosed OSA (OR, 2.20;
95% CI, 1.16-4.17; P ¼ .02) and 2,496 patients
diagnosed with OSA (OR, 0.75; 95% CI, 0.43-1.28;
P ¼ .29). Patients with a preoperative diagnosis of
OSA and preoperative prescription for CPAP were
less than half as likely to experience cardiovascular
complications as those diagnosed after surgery.30 The
risk of respiratory complications (OR, 2.08; 95% CI,
1.35-3.19; P < .001) was increased in both 2,629
patients with diagnosed OSA and 1,569 patients with
undiagnosed OSA. Most importantly, only patients
with severe or undiagnosed OSA had a signiﬁcantly
increased risk of respiratory and cardiovascular
complications. This is the ﬁrst study to show a
positive association between the severity of OSA
and postoperative risks. Prior negative studies were[ 1 4 9 # 2 CHES T F E B R U A R Y 2 0 1 6 ]
likely because of inadequate statistical power.53-55
Given the association between the severity of OSA
and postoperative outcomes, efforts targeting patients
with moderate-to-severe undiagnosed OSA in
preoperative screening may be more clinically
relevant.56-61
In another supporting study, Abdelsattar et al31
prospectively collected data from the Michigan Surgical
Quality Collaborative of 52 community and academic
hospitals in Michigan to compare postoperative 30-day
cardiopulmonary complications between treated and
untreated patients with OSA. Adult patients undergoing
various general or vascular surgeries were classiﬁed into
three groups: (1) no diagnosis or a low risk of OSA,
(2) documented OSA without therapy or suspicion of
OSA (snoring, tired, observed, pressure, BMI, age > 50
years, neck size large, gender [STOP-Bang] score $ 3 of
8), and (3) diagnosis of OSA with treatment (ie, positive
airway pressure [PAP] therapy). Of 26,842 patients,
2,646 (9.9%) had a diagnosis or suspicion of OSA and
55% of them were untreated. Compared with patients
with OSA undergoing PAP therapy, documented OSA
without therapy or suspicion of OSA was associated
with higher cardiopulmonary complications (risk-
adjusted rates, 6.7% vs 4%; adjusted OR, 1.8; P ¼.001).31
Other signiﬁcant predictors of adverse cardiopulmonary
outcomes were older age, higher American Society
of Anesthesiologists classes, vascular surgery, and
comorbidity index. Both myocardial infarction
(adjusted OR, 2.6; P ¼ .031) and unplanned
reintubations (adjusted OR, 2.5; P ¼ .003) were
signiﬁcantly higher in untreated patients with OSA.
These two large database studies provide incremental
evidence that conﬁrm the beneﬁts of establishing an
OSA diagnosis preoperatively and provide a solid
rationale for treating OSA with CPAP during the
perioperative period.30,31
Prospective Clinical Trials of PAP Therapy in
Surgical Patients With Undiagnosed OSA or
Untreated OSA
Starting treatment with autotitrating positive airway
pressure (APAP) can be as effective as CPAP treatment
with PSG titration.62-64 Because of possible ﬂuid shifts,
supine body position, and sedative effects of residual
anesthetics and narcotics, a single ﬁxed CPAP pressure
setting may not be equally effective in the perioperative
environment.65-68
Empiric APAP therapy has been studied in three
studies44,45,69 and successfully applied in thejournal.publications.chestnet.orgperioperative care of patients at risk for OSA (Table 3).
In the study by Guralnick et al69, surgical patients with
a STOP-Bang score of 3 or higher were referred to
undergo split night PSG and received APAP treatment
preoperatively. In an RCT, Liao et al44 investigated
the feasibility and effectiveness of perioperative APAP
in newly diagnosed untreated patients with OSA.
APAP treatment was started 3 days preoperatively,
allowing adaptation to the device and continued in the
postoperative period for 5 days. O’Gorman et al45
applied postoperative APAP empirically to orthopedic
patients who were considered at high risk of OSA
without preoperative PSG or PAP adaptation.
APAP treatment was shown to signiﬁcantly reduce
postoperative AHI and improve oxygen saturation
(SpO2) in patients with moderate and severe OSA.
44
Although APAP improved obstructive apneas and
hypopneas, a full resolution of SDB did not occur in
these studies. The preoperative AHI was reduced by an
average of 25 events/h postoperatively. Some residual
SDB persisted, with a mean AHI 12  16 events/h in
the recent meta-analysis.47 Brar et al67 found that
18% of surgical patients spent at least 30 min with
SpO2 < 90% the night following surgery despite the
use of their prescribed PAP therapy.67 The severity of
baseline OSA, pre-CPAP SpO2, net ﬂuid balance, total
IV opioid dose, and central apneas may be the
contributing factors to hypoxemia.12,13,60,65,67 As such,
it has been suggested that postoperative oximetry
monitoring may be indicated in PAP-treated patients
with OSA.67
In the meta-analysis of perioperative CPAP use, the
length of stay was 0.4 days shorter in the CPAP group
vs the no-CPAP group.47 On the contrary, O’Gorman
et al45 showed that there was no beneﬁt for APAP
applied postoperatively to patients who were identiﬁed
as being at high risk of OSA by screening vs patients
who receive usual care. The negative results of the
study may be due to a type 2 error, with an inadequate
sample size and inadequate oxygen supplementation
resulting from diluting effects of high ﬂow induced by
APAP.70Barriers to Preoperative Diagnosis of OSA and
Perioperative CPAP Therapy in Surgical
Patients
There are several barriers to effective diagnosis and
treatment of OSA in the perioperative setting. In both
clinical and research settings, a signiﬁcant proportion of591
TABLE 3 ] Prospective Clinical Trials of Positive Airway Pressure Therapy in Surgical Patients With Undiagnosed
OSA or Untreated OSA
Feature
Guralnick et al, 201269
(n ¼ 211)
Liao et al, 201344
(n ¼ 177)
O’Gorman et al, 201345
(n ¼ 138)
Study type Retrospective observational
study
RCT RCT
Study objective CPAP adherence during
perioperative period
Effect of APAP on AHI
and oxygenation
Effect of APAP on hospital stay
and postoperative Cx
Timing of APAP CPAP started preoperatively,
followed for adherence
postoperatively
3 days preoperatively
and 5 days
postoperatively
APAP started in PACU and during
night and whenever patient
sleeps
Study outcome Median CPAP adherence
2.5 h/night
Optimal pressure 9  2 cm H2O
APAP adherence 45%
Preoperative AHI
vs postoperative AHI
(NS)
APAP: 30.1 to 3.0
(P < .001)
No-APAP: 30.4 to 31.9
(P ¼ .302)
Any complications: 20.9
vs 23.3% (P ¼ 1.0)
LOS median, 5 vs 4 days; P ¼ .02
Duration of APAP
during ﬁrst night
after surgery
NA 4.1  5.3 h 6.2 h (1.3-9.3 h)
PAP adherence
(per night)
Median 2.5 h/night (0.7-4.5) 0-3.8 h/night,
mean 2.4-4.6 h/night
3.0 h (1.0-7.5 h/night)
See Table 1 legend for expansion of abbreviations.patients who may have suspected OSA refuse to undergo
additional testing for establishing an OSA diagnosis.44,69
Guralnick et al69 speculated that the inconvenience of an
overnight in-laboratory PSG or even out-of-center sleep
testing, the short time available between evaluation by
the anesthesia team and the actual date of surgery, cost,
underappreciation of the implications of undiagnosed
and untreated OSA by patients and clinicians, lack of
understanding of the consequences of untreated OSA,
and unwillingness to use CPAP may have all contributed
to the failure of surgical patients to accept and adhere to
perioperative diagnosis and treatment of OSA. These
reasons may explain why only approximately 45% of
patients with newly diagnosed OSA were adherent to
APAP therapy in the perioperative period.44,69 Other
factors that have been associated with reduced APAP
adherence in the perioperative period include African
American race, male gender, and depressive
symptomatology.69
In two studies, the optimal level of APAP was 9  2 cm
H2O in surgical patients with newly diagnosed OSA.
44,69
This information could be used empirically to prescribe
the minimum and maximum pressure settings on APAP
devices if clinicians need to prescribe APAP in the
postoperative period for patients suspected of having
OSA but who have not undergone formal sleep testing
or PAP titration.592 Contemporary Reviews in Sleep MedicinePostoperative CPAP utilization has been reported to
be suboptimal even in patients with an established
diagnosis of OSA. Gupta et al41 found that only one-
third of patients who were on home CPAP therapy used
their CPAP during the postoperative stay in the hospital.
Liao et al42 found that only 63% of patients on home
CPAP therapy received postoperative CPAP. Intensive
education of health-care professionals and patients is
needed to ensure that patients are instructed to bring
their CPAP device to the hospital and to continue to use
CPAP therapy during the vulnerable postoperative
period. In lieu of patients bringing their own CPAP
units, effective APAP therapy can be provided to the
patient by using hospital APAP or CPAP devices.
Who Are the Surgical Patients With OSA at
Increased Risk?
It is not known which subgroups of patients with SDB
are more likely to beneﬁt from PAP therapy. Patients
with obesity hypoventilation syndrome, overlap
syndrome, patients with severe OSA (AHI > 30), and
patients with a high arousal threshold with recurrent
severe hypoxemia may possibly beneﬁt from
preoperative PAP therapy. Patients with OSA and
unrecognized obesity hypoventilation syndrome or
overlap syndrome (COPD and OSA) had higher risks of
postoperative respiratory failure, heart failure, prolonged[ 1 4 9 # 2 CHES T F E B R U A R Y 2 0 1 6 ]
intubation, and longer ICU and hospital length of stay
than patients with nonhypercapnic OSA.71 Therefore,
hypercapnia can be an important risk modiﬁer.
Although many patients normally do not have
measurements of arterial blood gases, high serum
bicarbonate in venous blood can serve as a surrogate for
hypercapnia and may help to identify patients with
obesity hypoventilation syndrome.72-74 Identifying this
patient population is critical because CPAP use may not
be sufﬁcient and other advanced modes of PAP therapy
such as bilevel PAP with or without a backup rate may
have to be applied.
Recently, it was shown that 26% of patients without
OSA (preoperative AHI < 5) developed moderate-to-
severe SDB (AHI > 15) in the ﬁrst 1 to 3 days after
surgery.75 In these patients, preoperative respiratory
effort-related arousals may have converted to apneas or
hypopneas in the postoperative period, likely because of
increased upper airway collapsibility. The reasons
behind increased upper airway collapsibility may be
related to rostral ﬂuid shifts and/or respiratory
depression induced by opioids and sedatives.12,13,65,76,77
In this study, preoperative respiratory disturbance index,
rather than the AHI, and age were signiﬁcant predictors
of postoperative moderate-to-severe SDB.75 As a result,
it was suggested that in surgical patients, respiratory
disturbance index may be more useful than AHI in
diagnosing OSA.
Mutter et al30 identiﬁed patients with more severe OSA
(AHI > 30) to be at higher risk of adverse postoperative
cardiopulmonary events, but it is not known whether
AHI by itself is the best metric of OSA severity to risk
stratify perioperative patients with OSA. Other metrics
of OSA severity in the surgical patients such as mean
preoperative overnight SpO2, oxygen desaturation
index, and total sleep time below 90% SpO2 may be
useful as well. Chung et al60 found that patients with
mean preoperative overnight SpO2 < 93%, oxygen
desaturation index > 29 events/h or more than 7% total
sleep time < 90% SpO2 were at higher risk of
postoperative adverse events.
Another less-recognized cause of sudden death in
patients with OSA is arousal failure. It has been
suggested that an obstructive sleep apneic event may
not spontaneously terminate because of an ineffective
arousal mechanism related to impaired chemosensitivity
and/or opioid-induced respiratory depression, leading to
profound cerebral hypoxemia and ultimately death.76,77
Further research is necessary to determine the variousjournal.publications.chestnet.orgphenotypes of OSA and which metrics of SDB severity
are likely to predict postoperative adverse events.
Measures of hypoxemic exposure as well as hypercapnia
need to be taken into account when risk-stratifying
patients with SDB.60,78
Should We Use CPAP to Treat Patients With
Undiagnosed OSA?
Many anesthesiologists have become perioperative
physicians; in this important role, they are instrumental
in optimizing outcomes and minimizing complications
in surgical patients. Preoperative clinic is a “teachable
moment” for surgical patients with undiagnosed or
untreated OSA. Patients with OSA have evidence of
increased cardiopulmonary complications. There is
preliminary evidence supporting that patients with
OSA treated with CPAP have fewer postoperative
cardiopulmonary complications.30,31 Undiagnosed
patients with severe OSA have two to threefold increased
risk for cardiovascular and pulmonary complications.30
Given the preponderance of data on long-term beneﬁts
and improved prognosis of patients with OSA with
CPAP treatment, screening surgical patients for OSA
and initiating PAP therapy in the perioperative period
may be medically appropriate.79,80
With accumulating evidence from
studies,3,12,13,21,22,24,25,30,31,81,82 it may be ethically
difﬁcult to perform RCTs. Moreover, given the overall
low rates of postoperative complications, another
challenge is designing RCTs that are adequately powered
to detect these clinically meaningful outcomes.18 With
the increased awareness of postoperative complications
associated with OSA, researchers may face increasing
rates of unwillingness on the part of patients and their
physicians to participate in RCTs.56 The ﬁeld of
perioperative medicine is not unused to these challenges;
a similar dilemma regarding perioperative monitoring
with pulse oximetry occurred in the 1980s. Because of
the overall low rates of adverse events, RCTs have failed
to show differences in postoperative complications,
length of stay, or death between those monitored by
oximetry and control subjects.83 In spite of that,
anesthesiologists have universally adopted monitoring
patients with pulse oximetry in operating rooms and
PACUs. Subsequently, patients have beneﬁtted from
increased safety with anesthesia despite the absence
of positive ﬁndings of beneﬁts from RCTs on
oximetry monitoring. Another example is malignant
hyperthermia (MH), a serious complication.84 During
the past few decades, surgical patients are screened for a593
personal or family history of MH and an anesthesia
protocol is followed.84 Treatment with dantrolene is
initiated after MH occurs.84 These two historical
perspectives (oximetry monitoring and MH recognition)
may provide insights into how best to manage patients
with OSA in the perioperative period, with the ultimate
goal of increasing their safety. Surgical patients can be
screened for sleep apnea, appropriate CPAP treatment
may be given where appropriate, and postoperative
monitoring can be provided.
Who Might Have Beneﬁts With CPAP?
Surgical patients with OSA adherent to CPAP therapy
should continue their CPAP use postoperatively. The
management of patients nonadherent to CPAP or
suspected OSA is more challenging. It depends on
preexisting comorbidities, types and urgency of surgery,
requirement of postoperative opioids, and availability of
postoperative monitoring. There is a high prevalence of
OSA in surgical patients, which is in contrast with the
very low incidence of critical postoperative respiratory
events. The diagnosis of OSA per se cannot be
considered a diagnostic marker for respiratory
complications.85 Certain pathophysiological features of
OSA may enhance opioid induced ventilatory
impairment resulting from respiratory compromise or
suppression of the arousal response to airway
obstruction. Respiratory depression may be more
prominent in patients with OSA who have decreased
ventilatory responses to hypoxia/hypercapnia stimuli
and high arousal threshold with recurrent severe
hypoxemia.85 Patients should be informed that they
have been identiﬁed as either having a high probability
of OSA or as having a diagnosis of OSA with increased
risk of postoperative complications. Patients, surgeons,
and anesthesiologists should be jointly involved in the
decision-making whether to have additional
preoperative evaluations and/or consideration before
surgery. In the bariatric surgical patients with a high
prevalence of OSA, preparation for surgery with
screening and CPAP treatment are routinely performed
as part of the preoperative workup. Judgment and
common sense should be used to manage patients with
undiagnosed OSA or patients with OSA nonadherent to
CPAP therapy. Individual evaluation is important to
determine the best course of action. Referral to sleep
medicine for CPAP therapy may have to be taken in the
absence of overwhelming evidence from RCTs in certain
groups of patients. Patients with severe OSA, COPD or
overlap syndrome, obesity hypoventilation syndrome, or
pulmonary hypertension would deﬁnitely beneﬁt from594 Contemporary Reviews in Sleep Medicinefurther evaluation and workup. Patients who have
preoperative resting hypoxemia on room air with no
known cardiopulmonary cause are potential candidates
for further preoperative evaluation. Patients with
decreased respiratory responses to hypoxia/hypercapnia
stimuli and a high arousal threshold presenting with
recurrent severe hypoxemia may beneﬁt from
preoperative CPAP.Research Questions
Despite important advances, many important and
clinically relevant questions remain unanswered.47,78
How should OSA be screened and diagnosed in surgical
patients? Which phenotype of OSA would beneﬁt from
PAP therapy? When should we refer surgical patients
who are nonadherent to CPAP or have suspected OSA?
Should we refer these patients preoperatively and initiate
CPAP therapy if needed? Should we refer these patients
postoperatively and opt to minimize risk with
perioperative precautions and postoperative
monitoring? When is the optimal time to implement
PAP therapy? How should we monitor OSA patients
postoperatively? What are the best modalities of PAP
therapy for perioperative use? What are the reasons for
lack of adherence to PAP therapy and how can we
improve adherence to PAP therapy? What are the
obstacles to implementing a PAP protocol? What
therapeutic options should be used in PAP-intolerant
patients? What are the cost implication, cost-
effectiveness, and cost-beneﬁt considerations of
preoperative diagnosis of OSA and implementation of
PAP therapy? Without a doubt, more research is needed
to provide answers to some of these clinically relevant
questions. In the meantime, clinical acumen and a
commonsense approach is needed to identify surgical
patients with undiagnosed OSA who may be at risk for
postoperative adverse events who could beneﬁt from
CPAP therapy and postoperative monitoring.
In conclusion, diagnosing OSA and using perioperative
CPAP therapy may be effective interventions to reduce
the incidence of postoperative adverse outcomes in
patients with OSA undergoing surgery. Further research
in this area is needed to determine whether this strategy
has a positive effect on hospital resource utilization and
reduction in cost of the health-care system.
Acknowledgments
Financial/nonﬁnancial disclosures: The authors have reported to
CHEST the following: F. C. has received research support from
ResMed and the ResMed Foundation. B. M. has served as a consultant
to Philips/Respironics and has received research support from[ 1 4 9 # 2 CHES T F E B R U A R Y 2 0 1 6 ]
Philips/Respironics; he has also received honorarium from Zephyr
Medical Technologies and has served on the advisory board of Itamar
Medical. None declared (M. N., M. S.).
Role of sponsors: The sponsor had no role in the design of the study,
the collection and analysis of the data, or the preparation of the
manuscript.
References
1. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM.
Increased prevalence of sleep-disordered breathing in adults. Am J
Epidemiol. 2013;177(9):1006-1014.
2. Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-
disordered breathing in the general population: the HypnoLaus
study. Lancet Respir Med. 2015;3(4):310-318.
3. Memtsoudis SG, Stundner O, Rasul R, et al. The impact of sleep
apnea on postoperative utilization of resources and adverse
outcomes. Anesth Analg. 2014;118(2):407-418.
4. Mokhlesi B, Hovda MD, Vekhter B, Arora VM, Chung F,
Meltzer DO. Sleep-disordered breathing and postoperative outcomes
after elective surgery: analysis of the nationwide inpatient sample.
Chest. 2013;144(11):903-914.
5. Ramachandran SK, Kheterpal S, Consens F, et al. Derivation and
validation of a simple perioperative sleep apnea prediction score.
Anesth Analg. 2010;110(4):1007-1015.
6. Frey WC, Pilcher J. Obstructive sleep-related breathing disorders in
patients evaluated for bariatric surgery. Obes Surg. 2003;13(5):
676-683.
7. Hallowell PT, Stellato TA, Schuster M, et al. Potentially life-
threatening sleep apnea is unrecognized without aggressive
evaluation. Am J Surg. 2007;193(3):364-367.
8. Peker Y, Kraiczi H, Hedner J, Löth S, Johansson A, Bende M. An
independent association between obstructive sleep apnoea and
coronary artery disease. Eur Respir J. 1999;14(1):179-184.
9. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal
arrhythmias with sleep-disordered breathing: the Sleep Heart Health
Study. Am J Respir Crit Care Med. 2006;173(8):910-916.
10. Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of
sleep-disordered breathing and the occurrence of stroke. Am J Respir
Crit Care Med. 2005;172(11):1447-1451.
11. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PMA,
Wilding JPH. Obstructive sleep apnoea is independently associated
with an increased prevalence of metabolic syndrome. Eur Heart J.
2004;25(9):735-741.
12. Chung F, Liao P, Elsaid H, Shapiro CM, Kang WM. Factors
associated with postoperative exacerbation of sleep-disordered
breathing. Anesthesiology. 2014;120(2):299-311.
13. Chung F, Liao P, Yegneswaran B, Shapiro CM, Kang W.
Postoperative changes in sleep-disordered breathing and sleep
architecture in patients with obstructive sleep apnea. Anesthesiology.
2014;120(2):287-298.
14. Gross JB, Bachenberg KL, Benumof JL, et al. Practice guidelines for
the perioperative management of patients with obstructive sleep
apnea: a report by the American Society of Anesthesiologists Task
Force on perioperative management of patients with obstructive
sleep apnea. Anesthesiology. 2006;104(5):1081-1093.
15. American Society of Anesthesiologists Task Force on Perioperative
Management of patients with obstructive sleep apnea. Practice
guidelines for the perioperative management of patients with
obstructive sleep apnea. An updated report by the American Society
of Anesthesiologists Task Force on Perioperative Management of
patients with obstructive sleep apnea. Anesthesiology. 2014;120:
268-286.
16. Fouladpour N, Jesudoss R, Bolden N, Shaman Z, Auckley D.
Perioperative complications in obstructive sleep apnea patients
undergoing surgery: a review of the legal literature [published online
ahead of print June 23, 2015]. Anesth Analg.
17. Svider PF, Pashkova AA, Folbe AJ, et al. Obstructive sleep apnea:
strategies for minimizing liability and enhancing patient safety.
Otolaryngol Head Neck Surg. 2013;149(6):947-953.journal.publications.chestnet.org18. Memtsoudis SG, Besculides MC, Mazumdar M. A rude awakening
the perioperative sleep apnea epidemic. N Engl J Med. 2013;368(25):
2352-2353.
19. Chung F, Hillman D, Lydic R. Sleep medicine and anesthesia: a new
horizon for anesthesiologists. Anesthesiology. 2011;114(46):
1261-1262.
20. D’Apuzzo MR, Browne JA. Obstructive sleep apnea as a risk factor
for postoperative complications after revision joint arthroplasty.
J Arthroplasty. 2012;27(8):95-98.
21. Mokhlesi B, Hovda MD, Vekhter B, Arora VM, Chung F,
Meltzer DO. Sleep-disordered breathing and postoperative outcomes
after bariatric surgery: analysis of the nationwide inpatient sample.
Obes Surg. 2013;23(11):1842-1851.
22. Memtsoudis S, Liu SS, Ma Y, et al. Perioperative pulmonary
outcomes in patients with sleep apnea after noncardiac surgery.
Anesth Analg. 2011;112(1):113-121.
23. Memtsoudis SG, Stundner O, Rasul R, et al. Sleep apnea and total
joint arthroplasty under various types of anesthesia: a population-
based study of perioperative outcomes. Reg Anesth Pain Med.
2013;38(4):274-281.
24. Kaw R, Chung F, Pasupuleti V, Mehta J, Gay PC, Hernandez AV.
Meta-analysis of the association between obstructive sleep apnoea
and postoperative outcome. Br J Anaesth. 2012;109(6):897-906.
25. Hai F, Porhomayon J, Vermont L, Frydrych L, Jaoude P, El-Solh AA.
Postoperative complications in patients with obstructive sleep apnea:
a meta-analysis. J Clin Anesth. 2014;26(8):591-600.
26. Stundner O, Chiu YL, Sun X, et al. Sleep apnoea adversely affects the
outcome in patients who undergo posterior lumbar fusion: a
population-based study. Bone Joint J. 2014;96-B(2):242-248.
27. Young T, Evans L, Finn L, Palta M. Estimation of the clinically
diagnosed proportion of sleep apnea syndrome in middle-aged men
and women. Sleep. 1997;20(9):705-706.
28. Singh M, Liao P, Kobah S, Wijeysundera DN, Shapiro C, Chung F.
Proportion of surgical patients with undiagnosed obstructive sleep
apnoea. Br J Anaesth. 2013;110(4):629-636.
29. Chung F, Yegneswaran B, Liao P, et al. Validation of the Berlin
questionnaire and American Society of Anesthesiologists checklist as
screening tools for obstructive sleep apnea in surgical patients.
Anesthesiology. 2008;108(5):822-830.
30. Mutter TC, Chateau D, Moffatt M, Ramsey C, Roos LL, Kryger M.
A matched cohort study of postoperative outcomes in obstructive
sleep apnea: could preoperative diagnosis and treatment prevent
complications? Anesthesiology. 2014;121(4):707-718.
31. Abdelsattar ZM, Hendren S, Wong SL, Campbell DA,
Ramachandran SK. The impact of untreated obstructive sleep apnea
on cardiopulmonary complications in general and vascular surgery:
a cohort study. Sleep. 2015;38(8):1205-1210.
32. Ferreyra GP, Baussano I, Squadrone V, et al. Continuous positive
airway pressure for treatment of respiratory complications after
abdominal surgery: a systematic review and meta-analysis. Ann Surg.
2008;247(4):617-626.
33. Squadrone V, Coha M, Cerutti E, et al. Continuous positive airway
pressure for treatment of postoperative hypoxemia: a randomized
controlled trial. JAMA. 2005;293(5):589-595.
34. Kindgen-Milles D, Müller E, Buhl R, et al. Nasal-continuous positive
airway pressure reduces pulmonary morbidity and length of hospital
stay following thoracoabdominal aortic surgery. Chest. 2005;128(2):
821-828.
35. Zarbock A, Mueller E, Netzer S, Gabriel A, Feindt P, Kindgen-
Milles D. Prophylactic nasal continuous positive airway pressure
following cardiac surgery protects from postoperative pulmonary
complications: a prospective, randomized, controlled trial in 500
patients. Chest. 2009;135(5):1252-1259.
36. Debas HT. The emergence and future of global surgery in the United
States. JAMA Surg. 2015;150(9):933-934.
37. Kain ZN, Vakharia S, Garson L, Engwall S, Schwarzkopf R, Gupta R,
Cannesson M. The perioperative surgical home as a future
perioperative practice model. Anesth Analg. 2014;118(5):1126-1130.595
38. Chung F, Mokhlesi B. Postoperative complications associated with
obstructive sleep apnea: time to wake up! Anesth Analg. 2014;118(2):
251-253.
39. Mehta V, Subramanyam R, Shapiro CM, Chung F. Health effects of
identifying patients with undiagnosed obstructive sleep apnea in the
preoperative clinic: a follow-up study. Can J Anaesth. 2012;59(6):
544-555.
40. Rennotte MT, Baele P, Aubert G, Rodenstein DO. Nasal continuous
positive airway pressure in the perioperative management of patients
with obstructive sleep apnea submitted to surgery. Chest.
1995;107(2):367-374.
41. Gupta RM, Parvizi J, Hanssen AD, Gay PC. Postoperative
complications in patients with obstructive sleep apnea syndrome
undergoing hip or knee replacement: a case-control study. Mayo
Clin Proc. 2001;76(9):897-905.
42. Liao P, Yegneswaran B, Vairavanathan S, Zilberman P, Chung F.
Postoperative complications in patients with obstructive sleep apnea:
A retrospective matched cohort study. Can J Anaesth. 2009;56:
819-828.
43. Jensen C, Tejirian T, Lewis C, Yadegar J, Dutson E, Mehran A.
Postoperative CPAP and BiPAP use can be safely omitted after
laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis.
2008;4(4):512-514.
44. Liao P, Luo Q, Elsaid H, Kang W, Shapiro CM, Chung F.
Perioperative auto-titrated continuous positive airway pressure
treatment in surgical patients with obstructive sleep apnea: a
randomized controlled trial. Anesthesiology. 2013;119(4):837-847.
45. O’Gorman SM, Gay PC, Morgenthaler TI. Does autotitrating
positive airway pressure therapy improve postoperative outcome in
patients at risk for obstructive sleep apnea syndrome? A randomized
controlled clinical trial. Chest. 2013;144(1):72-78.
46. Proczko MA, Stepaniak PS, de Quelerij M, et al. STOP-Bang and the
effect on patient outcome and length of hospital stay when patients
are not using continuous positive airway pressure. J Anesth.
2014;28(6):891-897.
47. Nagappa M, Mokhlesi B, Wong J, Wong DT, Kaw R, Chung F. The
effects of continuous positive airway pressure on postoperative
outcomes in obstructive sleep apnea patients undergoing surgery: a
systematic review and meta-analysis. Anesth Analg. 2015;120(5):
1013-1023.
48. Meng L. Postoperative nausea and vomiting with application of
postoperative continuous positive airway pressure after laparoscopic
gastric bypass. Obes Surg. 2010;20(7):876-880.
49. Neligan PJ, Malhotra G, Fraser M, Williams N, Greenblatt EP,
Cereda M, Ochroch EA. Continuous positive airway pressure via the
Boussignac system immediately after extubation improves lung
function in morbidly obese patients with obstructive sleep apnea
undergoing laparoscopic bariatric surgery. Anesthesiology.
2009;110(4):878-884.
50. Hallowell PT, Stellato TA, Petrozzi MC, Schuster M, Graf K,
Robinson A, Jasper JJ. Eliminating respiratory intensive care unit
stay after gastric bypass surgery. Surgery. 2007;142(4):608-612.
51. Huerta S, DeShields S, Shpiner R, et al. Safety and efﬁcacy of
postoperative continuous positive airway pressure to prevent
pulmonary complications after Roux-en-Y gastric bypass.
J Gastrointest Surg. 2002;6:354-358.
52. Ramirez A, Lalor PF, Szomstein S, Rosenthal RJ. Continuous positive
airway pressure in immediate postoperative period after laparoscopic
Roux-en-Y gastric bypass: is it safe? Surg Obes Relat Dis. 2009;5(5):
544-546.
53. Kaw R, Pasupuleti V, Walker E, Ramaswamy A, Foldvary-Schafer N.
Postoperative complications in patients with obstructive sleep apnea.
Chest. 2012;141(2):436-441.
54. Weingarten TN, Flores AS, McKenzie JA, et al. Obstructive sleep
apnoea and perioperative complications in bariatric patients. Br J
Anaesth. 2011;106(1):131-139.
55. Bryson GL, Gomez CP, Jee RM, Blackburn J, Taljaard M, Forster AJ.
Unplanned admission after day surgery: a historical cohort study in
patients with obstructive sleep apnea. Can J Anaesth. 2012;59(9):
842-851.596 Contemporary Reviews in Sleep Medicine56. Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to
screen patients for obstructive sleep apnea. Anesthesiology.
2008;108(5):812-821.
57. Chung F, Subramanyam R, Liao P, Sasaki E, Shapiro C, Sun Y. High
STOP-Bang score indicates a high probability of obstructive sleep
apnoea. Br J Anaesth. 2012;108(5):768-775.
58. Chung F, Yang Y, Brown R, Liao P. Alternative scoring models of
STOP-bang questionnaire improve speciﬁcity to detect undiagnosed
obstructive sleep apnea. J Clin Sleep Med. 2014;10(9):951-958.
59. Chung F, Chau E, Yang Y, Liao P, Hall R, Mokhlesi B. Serum
bicarbonate level improves speciﬁcity of STOP-Bang screening for
obstructive sleep apnea. Chest. 2013;143(5):1284-1293.
60. Chung F, Zhou L, Liao P. Parameters from preoperative overnight
oximetry predict postoperative adverse events. Minerva Anestesiol.
2014;80(10):1084-1095.
61. Chung F, Liao P, Farney R. Correlation between the STOP-Bang
score and the severity of obstructive sleep apnea. Anesthesiology.
2015;122(6):1436-1437.
62. Masa JF, Jiménez A, Durán J, et al. Alternative methods of titrating
continuous positive airway pressure: a large multicenter study. Am J
Respir Crit Care Med. 2004;170(11):1218-1224.
63. Mulgrew AT, Fox N, Ayas NT, Ryan CF. Diagnosis and initial
management of obstructive sleep apnea without polysomnography: a
randomized validation study. Ann Intern Med. 2007;146(3):157-166.
64. Kushida CA, Berry RB, Blau A, et al. Positive airway pressure
initiation: a randomized controlled trial to assess the impact of
therapy mode and titration process on efﬁcacy, adherence, and
outcomes. Sleep. 2011;34(8):1083-1092.
65. Yadollahi A, Gabriel JM, White LH. Taranto Montemurro L,
Kasai T, Bradley TD. A randomized, double crossover study to
investigate the inﬂuence of saline infusion on sleep apnea severity
in men. Sleep. 2014;37(10):1699-1705.
66. Ramachandran SK. Can intravenous ﬂuids explain increased
postoperative sleep disordered breathing and airway outcomes?
Sleep. 2014;37(10):1587-1588.
67. Brar IS, Sharma R, Khanna G, Auckley D. CPAP for obstructive
sleep apnea in the post-operative setting: an oximetry evaluation
study. J Sleep Disord Ther. 2013;2:7.
68. Lam TD, Singh M, Chung F. Salt content in IV ﬂuids given
intraoperatively may inﬂuence postoperative OSA severity. Sleep.
2015;38(6):989.
69. Guralnick AS, Pant M, Minhaj M, Sweitzer BJ, Mokhlesi B. CPAP
adherence in patients with newly diagnosed obstructive sleep apnea
prior to elective surgery. J Clin Sleep Med. 2012;8(5):501-556.
70. Mokhlesi B. Empiric postoperative autotitrating positive airway
pressure therapy generating evidence in the perioperative care of
patients at risk for obstructive sleep apnea. Chest. 2013;144(1):5-7.
71. Kaw R, Bhateja P, Paz Y, et al. Postoperative complications in
patients with unrecognized obesity hypoventilation syndrome
undergoing elective non-cardiac surgery [published online ahead
of print May 21, 2015] Chest. 2015. http://dx.doi.org/10.1378/chest.
14-3216.
72. Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT.
Obesity hypoventilation syndrome: prevalence and predictors in
patients with obstructive sleep apnea. Sleep Breath. 2007;11(2):
117-124.
73. Bingol Z, Pıhtılı A, Cagatay P, Okumus G, Kıyan E. Clinical
predictors of obesity hypoventilation syndrome in obese subjects
with obstructive sleep apnea. Respir Care. 2015;60(5):666-672.
74. BaHammam AS. Prevalence, clinical characteristics, and predictors
of obesity hypoventilation syndrome in a large sample of Saudi
patients with obstructive sleep apnea. Saudi Med J. 2015;36(2):
181-189.
75. Chung F, Liao P, Yang Y, et al. Postoperative sleep-disordered
breathing in patients without preoperative sleep apnea. Anesth
Analg. 2015;120(6):1214-1224.
76. Lynn LA, Curry JP. Patterns of unexpected in-hospital deaths: a root
cause analysis. Patient Saf Surg. 2011;5(1):3.[ 1 4 9 # 2 CHES T F E B R U A R Y 2 0 1 6 ]
77. Correa D, Farney RJ, Chung F, Prasad A, Lam D, Wong J. Chronic
opioid use and central sleep apnea: a review of the prevalence,
mechanisms, and perioperative considerations. Anesth Analg.
2015;120(6):1273-1285.
78. Cooksey J, Mokhlesi B. Postoperative complications in obesity
hypoventilation syndrome and hypercapnic OSA: CO2 matters!
Chest. 2015;149(1):11-13.
79. Gay PC. The value of assessing risk of obstructive sleep apnea in
surgical patients: it only takes one. J Clin Sleep Med. 2010;6(5):
473-474.
80. Chung F. It may be unsafe for patients with untreated severe OSA
requiring postoperative narcotic to undergo ambulatory surgery.
J Clin Sleep Med. 2011;7(1):111-113.journal.publications.chestnet.org81. Stundner O, Chiu Y-L, Sun X, et al. Sleep apnoea adversely affects
the outcome in patients who undergo posterior lumbar fusion: a
population-based study. Bone Joint J. 2014;96-B(2):242-248.
82. Mokhlesi B, Pamidi S, Yaggi HK. Sleep disordered breathing and
subjective sleepiness in the elderly: a deadly combination? Sleep.
2011;34(4):413-415.
83. Pedersen T, Møller AM, Hovhannisyan K. Pulse oximetry for
perioperative monitoring. Cochrane database Syst Rev. 2009;(4):
CD002013.
84. Hopkins PM. Malignant hyperthermia: advances in clinical
management and diagnosis. Br J Anaesth. 2000;85(1):118-128.
85. Doufas AG. Obstructive sleep apnea, pain, and opioid analgesia in
the postoperative patient. Curr Anesthesiol Rep. 2014;4:1-9.597
